콘텐츠로 건너뛰기
Merck
  • Mass Spectrometry Imaging of Lipids in Human Skin Disease Model Hidradenitis Suppurativa by Laser Desorption Ionization from Silicon Nanopost Arrays.

Mass Spectrometry Imaging of Lipids in Human Skin Disease Model Hidradenitis Suppurativa by Laser Desorption Ionization from Silicon Nanopost Arrays.

Scientific reports (2019-11-27)
Jarod A Fincher, Derek R Jones, Andrew R Korte, Jacqueline E Dyer, Paola Parlanti, Anastas Popratiloff, Christine A Brantner, Nicholas J Morris, Russell K Pirlo, Victoria K Shanmugam, Akos Vertes
초록

Neutral lipids have been implicated in a host of potentially debilitating human diseases, such as heart disease, type-2 diabetes, and metabolic syndrome. Matrix-assisted laser desorption ionization (MALDI), the method-of-choice for mass spectrometry imaging (MSI), has led to remarkable success in imaging several lipid classes from biological tissue sections. However, due to ion suppression by phospholipids, MALDI has limited ability to efficiently ionize and image neutral lipids, such as triglycerides (TGs). To help overcome this obstacle, we have utilized silicon nanopost arrays (NAPA), a matrix-free laser desorption ionization (LDI) platform. Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease of the apocrine sweat glands. The ability of NAPA to efficiently ionize lipids is exploited in the analysis of human skin samples from sufferers of HS. Ionization by LDI from NAPA allows for the detection and imaging of a number of neutral lipid species, including TGs comprised of shorter, odd-chain fatty acids, which strongly suggests an increased bacterial load within the host tissue, as well as hexosylceramides (HexCers) and galabiosyl-/lactosylceramides that appear to be correlated with the presence of HS. Our results demonstrate that NAPA-LDI-MSI is capable of imaging and potentially differentiating healthy and diseased human skin tissues based on changes in detected neutral lipid composition.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Carboxymethylcellulose sodium salt, Medium viscosity
Avanti
C24:1 Lactosyl(β) Ceramide (d18:1/24:1), Avanti Polar Lipids 860597P, powder
Avanti
C16 Lactosyl(β) Ceramide (d18:1/16:0), Avanti Polar Lipids 860576P, powder
Avanti
C17 Lactosyl(β) Ceramide (d18:1/17:0), Avanti Polar Lipids 860595P, powder